Thailand Medical News

COVID-19 Genomics: Swiss Researchers Discover How SARS-CoV-2 NSP1 Protein Inhibits Host Translation. Findings Has Implications For Vaccines And Drugs

Source: COVID-19 Genomics Jul 09, 2020 5 years ago

COVID-19 Genomics: Swiss Researchers from the Institute of Molecular Biology and Biophysics-Zurich, University of Bern and Institute of Virology and Immunology-Bern have discovered the detailed functional process by which the SARS-CoV-2 coronavirus NSP1 Protein Inhibits Host Translation. Their study published in a preprint server shows that the 5’ end of the RNA molecule is ca...

COVID-19 Disinfectants: EPA Approves First SARS-CoV-2 Disinfection Sprays By Lysol After Only Study On Effectiveness Of Disinfectants Against COVID-19

Source: COVID-19 Disinfectants Jul 09, 2020 5 years ago

COVID-19 Disinfectants: The American Environmental Protection Agency (EPA) just approved two disinfection sprays that can kill severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), on surfaces. The agency gave the green light to Lysol Disinfectant Spray, and Lysol Disinfectant Max Cover Mist, as two products that can effectively kil...

MUST READ! COVID-19 Nutrition: European Study Links Consumption Of Fermented And Pickled Vegetables To Low COVID-19 Mortality

Source: COVID-19 Nutrition Jul 09, 2020 5 years ago

COVID-19 Nutrition: A new but intriguing European study involving the collaboration of 13 research centers and universities in Germany, Spain, Portugal, Franca and Switzerland suggests that COVID-19 mortality rates are likely to be lower in countries where diets are rich in fermented vegetables. Though the study is published on a preprint server, it is currently being peer-reviewed by a f...

COVID-19 Diagnostics: University of Exeter’s New Next-Generation Triple Antibody Test for COVID-19 Secures UK Regulatory Approval

Source: COVID-19 Diagnostics Jul 09, 2020 5 years ago

COVID-19 Diagnostics: Researchers from the University of Exeter have developed a revolutionary new device that could allow health professionals to accurately test patients' antibody response to COVID-19 in as little as seven minutes. The new pioneering COVID-19 Triple Antibody Test has been produced by the University of Exeter spin-out company Attomarker Ltd and is set to spearhead th...

BREAKING NEWS! COVID-19 Alert: Research Led By Cedars-Sinai Indicates That Proton Pump Inhibitors (PPIs) Use Is Linked To Increased Risk Of COVID-19

Source: COVID-19 Alert Jul 08, 2020 5 years ago

COVID-19 Alert: Medical researchers from Cedars-Sinai Medical Center, Michigan Medicine and UCLA Fielding School of Public Health have found an association between proton pump inhibitors (PPIs) and risk of COVID-19 in an observational study of more than 53,000 Americans.It was found that PPIs usage was linked with a higher risk for COVID-19. This places the usage of PPIs for heartburn and gastric...

BREAKING! COVID-19 Antibodies: American Researchers Develop Synthetic Antibody ACE2-IgG1 That Could Prevent And Treat COVID-19

Source: COVID-19 Antibodies Jul 08, 2020 5 years ago

COVID-19 Antibodies: Researchers from Tulane University-New Orleans, University of Illinois-Chicago and University of Georgia have created a synthetic antibody that on mouse models demonstrated to neutralize the SARS-CoV-2 coronavirus. This could help prevent infection as well as treat COVID-19 in those who already have it. Typically the SARS-CoV-2 coronavirus, gains entry into cells...

COVID-19 Research: SARS-CoV-2 Evades Antibodies By Having Glycans Masking Its Binding Sites. New Study Reveals Epitopes Not Shielded By These Polysaccharides

Source: COVID-19 Research Jul 08, 2020 5 years ago

COVID-19 Research: German researchers from Max Planck Institute, Frankfurt Institute for Advanced Studies and the Institute of Biophysics, Goethe University-Frankfurt have conducted a news study on the structural dynamics of the SARS-CoV-2 spike protein and have identified epitopes that could be possible immune targets for the development of vaccines or other therapeutics. The resear...

COVID-19 Neurology: German Study Shows That Autoantibodies From The Cerebrospinal Fluid Targets The Brain In Certain COVID-19 Patients

Source: COVID-19 Neurology Jul 08, 2020 5 years ago

COVID-19 Neurology: German researchers from Charité - Universitätsmedizin Berlin have shown that the neurological symptoms observed in some COVID-19 patients may be caused by autoantibodies targeting the brain. The research team says that although some autoantibodies still need to be identified, they may at least partly explain the multiple organ disease that can occur in COVI...

COVID-19 Drugs: Queensland University of Technology and Oxford University Exploring Budesonide Inhaler Therapy For Early COVID-19 Patients In New Trial

Source: COVID-19 Drugs Jul 08, 2020 5 years ago

COVID-19 Drugs: Medical researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection. Research has shown that some corticosteroids,&nbs...

COVID-19 Innovations: University Of Houston Researchers Develop Air Filters That Can Kill SARS-CoV-2 Coronavirus

Source: COVID-19 Innovations Jul 08, 2020 5 years ago

COVID-19 Innovations: Experts from the University of Houston, in collaboration with a private company called Medistar, have designed a "catch and kill" air filter that can trap the coronavirus responsible for COVID-19, killing it instantly. Dr Zhifeng Ren, director of the Texas Center for Superconductivity at UH, collaborated with Monzer Hourani, CEO of Medistar, a Houston-based...

COVID-19 Vaccine Updates: Novavax Secures US$1.6 Billion in “Warp Speed” Funding, To Start Production Of 100 Million Doses of NVX-CoV2373 Vaccine

Source: COVID-19 Vaccine Updates Jul 08, 2020 5 years ago

COVID-19 Vaccine Updates: Maryland based Biotech company Novavax announced that it has been awarded US$1.6 billion toward late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine starting this year through the Trump’s administration “Operation Warp Speed” program. The new funding will enable Novavax to complete la...

BREAKING! COVID-19 Neurology: Study Says More Neurological Complications Arising In COVID-19 Including ADEM (Acute Disseminated Encephalomyelitis)

Source: COVID-19 Neurology Jul 08, 2020 5 years ago

COVID-19 Neurology: A new study by University College London (UCL) and University College London Hospitals (UCLH) indicate that more neurological conditions are being manifested in COVID-19 patients. Besides delirium, brain inflammation, stroke and nerve damage, a large number of patients are now shown to be inflicted with ADEM or Acute Disseminated Encephalomyelitis and its prevalence is gr...

BREAKING! Guillain-Barre Syndrome- A Rare Neurological Disorder Manifesting In More COVID-19 Patients

Source: Guillain-Barre Syndrome And COVID-19 Jul 08, 2020 5 years ago

Guillain-Barre Syndrome: A new peer-reviewed study published in the Journal of Clinical Neuromuscular Disease by researchers from Department of Neurology and Neuroscience Institute, Allegheny General Hospital Pittsburgh, Pennsylvania show that COVID-19 is linked with Guillain-Barre Syndrome. https://journals.lww.com/jcnmd/FullText/2020/06000/Novel_Coronavirus__COVID_19__Associated.7.aspx ...

COVID-19 Clinical Care: Researchers Warn As To How And When Type III Interferon Should Be Used In COVID-19 To Prevent Harmful Effects

Source: COVID-19 Clinical Care Jul 08, 2020 5 years ago

COVID-19 Clinical Care: A new study by researchers from Boston Children’s Hospital warns about how and when type III Interferons should be used in the treatment of COVID019 as using it in later stages of severity can do more harm. The research findings were published in the journal: Science. https://science.sciencemag.org/content/early/2020/06/10/science.abc3545 The human imm...

Otolaryngology: Dutch Study Shows That Many Will Develop Deafness In Adult Life Due to Common Inherited Genetic Variant RIPOR2

Source: Otolaryngology Jul 07, 2020 5 years ago

Otolaryngology: A new study published in the Journal of Medical Genetics shows that a common inherited genetic variant is a frequent cause of deafness in adults with implications that many thousands of people are potentially at risk. For a long time deafness in adults is known to be inherited. But, unlike childhood deafness, the genetic causes largely remain a mystery, say ...

COVID-19 Research: Study Shows Individuals With Liver Fibrosis Linked To Ventilator Need In COVID-19

Source: COVID-19 Research-Liver Fibrosis Jul 07, 2020 5 years ago

COVID-19 Research: According to researchers in Spain, middle-aged COVID-19 patients showing signs of advanced liver fibrosis, as estimated by the Fibrosis Index Based on 4 Factors (FIB-4), are at greater likelihood of requiring mechanical ventilation. Dr Luis Ibanez-Samaniego from the Hospital General Universitario Gregorio Maran, in Madrid who is the lead researcher said that not m...

MUST READ! COVID-19 Warnings: High Blood Pressure Drug Captopril Associated With Pulmonary Adverse Reactions In COVID-19 Patients With Diabetes

Source: COVID-19 Warnings- Captopril Jul 07, 2020 5 years ago

COVID-19 Warnings: A US based study involving researchers from University of Missouri Kansas City School of Pharmacy, Kansas State University and North Carolina State University has found that the high blood pressure drug Captopril to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers (ARBs). ...

BREAKING! COVID-19 Seroprevalence: Only 5% Of The Population In Spain Found To Have SARS-CoV-2 Antibodies

Source: COVID-19 Seroprevalence Jul 07, 2020 5 years ago

COVID-19 Seroprevalence: The Spanish ENE-COVID national seroprevalence study concludes that 5% of its population has antibodies. This percentage has hardly changed in the three waves of which the study consists: in the first it was estimated at 5% and in the second and third it was 5.2%, results that confirm that, despite the great impact of the pandemic in Spain, the figures are not high, which r...

COVID-19 Case Study: Utilizing Functional MRI On Unresponsive COVID-19 Patients Offers Hope for Recovery

Source: COVID-19 Case Study Jul 07, 2020 5 years ago

COVID-19 Case Study: Numerous patients with severe COVID-19 remain unresponsive after surviving critical illness. Medical Researchers from Massachusetts General Hospital (MGH) presents a case in which a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated functionally intact brain connections when functional MRI was used and we...

BREAKING! COVID-19 Research: SARS-CoV-2 Spike Proteins Evades Immune Response By Antibodies Through Fluctuations In Acidity Levels

Source: COVID-19 Research Jul 07, 2020 5 years ago

COVID-19 Research: In a new study by researchers from US NIH, Columbia University and John Hopkins University, it has been shown that the SARS-CoV-2 coronavirus is proving itself to be an elusive foe, evading immune surveillance while instigating hyper-inflammatory responses that eventually destroy the host in a significant minority of cases. The study reports the role of pH in helping the virus e...

COVID-19 Vaccine News: Johnson And Johnson Contracts Emergent BioSolutions For 5 Year, I Billion Doses Of Ad26.COV2-S Vaccine Manufacturing Deal

Source: COVID-19 Vaccine News Jul 07, 2020 5 years ago

COVID-19 Vaccine News: Biotech manufacturing company-Emergent BioSolutions, based in Maryland, entered a five-year manufacturing services deal with Janssen Pharmaceutical, a Johnson & Johnson company, to manufacture J&J’s Ad26.COV2-S COVID-19 vaccine. Emergent will handle contract development and manufacturing (CDMO) services in a deal that is valued at ...

COVID-19 Antibodies: Regeneron Pharmaceuticals Antibody Cocktail REGN-COV2 Progresses To Phase III Clinical Trials

Source: COVID-19 Antibodies Jul 07, 2020 5 years ago

COVID-19 Antibodies: New York based Regeneron Pharmaceuticals announced its double-antibody cocktail against COVID-19 is advancing into Phase III studies, less than a month after the start of its first clinical trial, with preliminary data from one study expected to be reported later this summer. Regeneron's Biotech Plant The biotech company said it is proceeding with clinical develop...

COVID-19 Medical Devices: Neural Analytics Inc Launches New Robotic Transcranial Doppler for Stroke Detection And Risk Assessment In COVID-19 Patients

Source: COVID-19 Medical Devices Jul 07, 2020 5 years ago

COVID-19 Medical Devices: To date, emerging studies suggests that COVID-19 patients are at a higher risk of stroke and promptly diagnosing and treating such patients is a priority in hospitals across the world. Furthermore, identifying which COVID-19 patients are at increased risk of developing a stroke is also important, and may help with preemptive treatment and monitoring. Los A...

COVID-19 Vaccine Updates: South Australia’s Flinders University Commences Phase 1 Trial Of COVID-19 Vaccine COVAX-19 Developed By Vaxine Pty Ltd

Source: COVID-19 Vaccine Updates Jul 07, 2020 5 years ago

COVID-19 Vaccine Updates: It was announced that vaccine candidate COVAX-19 developed by Vaxine Pty Ltd and Flinders University will commence Phase 1 trials at the Royal Adelaide Hospital (RAH) to test its efficacy. The phase I trial will provide initial safety and immune response data on 40 healthy participants aged between 18 and 65 years who have already been pre-screened. Resear...

COVID-19 Drugs: University Of South Florida And University Of Arizona Researchers Identify Drug Candidates That Target The Viral Protease MPro

Source: COVID-19 Drugs Jul 07, 2020 5 years ago

COVID-19 Drugs: Researchers from University of South Florida Health (USF Health) Morsani College of Medicine scientists along with pharmaceutical experts from the University of Arizona College of Pharmacy have identified several existing drug compounds that block replication of the COVID-19 virus (SARS-CoV-2) within human cells grown in the laboratory. The identified inhibitors all demon...

COVID-19 Research: Russian Researcher Hypothesize That Severity In COVID-19 Could Be Due Blood Glycoprotein Called Von Willebrand Factor

Source: COVID-19 Research Jul 07, 2020 5 years ago

COVID-19 Research: A new study by Dr Anna Aksenova, a senior research associate at the Laboratory of Amyloid Biology at St Petersburg University, has advanced a hypothesis that the severe course of COVID-19 may be associated with the von Willebrand factor, a blood glycoprotein that is one of the main components of the blood coagulation system. The research findings have been peer re...

BREAKING! COVID-19 Research: US Military Research Says SARS-CoV-2 Coronavirus Can Remain Active On Animal Skin For Up To 4 days At Room Temperature

Source: COVID-19 Research Jul 07, 2020 5 years ago

COVID-19 Research: A research in which US Military bioweapon researchers tested the stability of the SARS-CoV-2 pathogen on various surfaces, including paper currency and pig skin showed that the novel coronavirus can live for days on animal skin at room temperature and even up to 2 weeks on refrigerated pig skin. The study has huge implications in the food industry, meat processing plant...

Gold Protective Mask And Gem Studded Masks, A New Trend In COVID-19 Infested India!

Source : Masks Jul 06, 2020 5 years ago

We apologize to readers first for posting such an article on our site but we simply just could not resist the kind of stupidity materializing from the COVID-19 pandemic! While many Americans and Europeans are refusing to wear protective mask against the SARS-V-2 coronavirus either due to political reasons or sheer stupidity, across the globe in India, we have the protective mask evolving into a f...

BREAKING NEWS! China Reporting Outbreak Of Bubonic Plague In Bayanur District In Inner Mongolia Autonomous Region

Source: Bubonic Plague China Jul 06, 2020 5 years ago

Bubonic Plague: China health authorities have reported an outbreak of Bubonic Plague in the inner Mongolia Autonomous Region. Bubonic plague, caused by bacterial infection, was responsible for one of the deadliest epidemics in human history ie the Black Death which killed about 50 million people across Africa, Asia and Europe in the 14th Century. There have been a handful of ...

BREAKING! GOVID-19 Genomics: Major Genetic Risk Variant Identified On SARS-CoV-2 Was Inherited 60,000 Years Ago From The Neanderthals!

Source: COVID-19 Genomics Jul 06, 2020 5 years ago

GOVID-19 Genomics: A major genetic risk variant found on the SARs-CoV-2 coronavirus RNA which comprises of a stretch of six genes that seems to increase the risk of severe illness from the coronavirus was found to be part of a stretch of DNA passed down from Neanderthals 60,000 years ago, according to a new study by genomic experts from the Max Planck Institute for Evolutionary Anthropology-German...

COVID-19 Vaccine: Oxford’s and AstraZenaca’s ChAdOx1 Vaccine Progresses Into Phase III Human Trials

Source: COVID-19 Vaccine Jul 06, 2020 5 years ago

COVID-19 Vaccine: Professor of vaccinology at the University of Oxford, and one of the scientists leading the vaccine initiative, Dr Sarah Gilbert, told the U.K.'s Science and Technology Committee last week that their candidate vaccine has progressed to the phase III trial in the United Kingdom. Phase III trials typically involves tens of thousands of research participants acros...

BREAKING! Flu Vaccine: Study In Brazil Shows That Trivalent Or Quadrivalent Influenza Vaccine Associated With Reduced Risk Of COVID-19 Severity And Mortality

Source: Flu Vaccine Jul 06, 2020 5 years ago

Flu Vaccine: Researchers from the Swiss Tropical and Public Health Institute, the University of Basel and University of Sao Paulo Medical School in a new research involving over 92,000 patients with COVID-19 in Brazil shows that the risks of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent influenza vaccine. The research findings were printed on a pre...

COVID-19 Diagnostics: UVA Researchers Say That Cytokine IL-13 Can Be Used As A Blood Test Biomarker To Determine COVID-19 Severity

Source: COVID-19 Diagnostics Jul 06, 2020 5 years ago

COVID-19 Diagnostics: A new research from the University of Virginia (UVA) School of Medicine suggests doctors can examine COVID-19 patients' blood to identify those at greatest risk of severe illness and to pinpoint those most likely to need a ventilator. The main biomarker that should be looked out for is the cytokine IL-13 (Interleukin 13). High levels of IL-13 were associated with worsened...

Generic Remdesivir: While Americans Have To Pay Up To US$3120 For Gilead’s Remdesivir, Price War In India Has Led Prices Dropping To Below US$50!

Source: Generic Remdesivir Jul 06, 2020 5 years ago

Generic Remdesivir: The Trump administration last week proudly announced that it had secured 500,000 doses of Gilead’s remdesivir at prices that were set by Gilead at between US$2,340 to US$3,120. https://www.thailandmedical.news/news/breaking-remdesivir-gilead-sets-price-at-us$2,340-to-us$3,120-for-drug-that-has-no-safety-studies-or-true-efficacy-except-that-it-shortens-hospitaliza ...

WHO Is Spreading Misinformation! 293 Scientific Experts Challenge and Say That SARS-CoV-2 is Airborne. Retaliation Called Against WHO

Source: SARS-CoV-2 Is Airborne Jul 06, 2020 5 years ago

WHO: Despite mounting evidence that the SARS-CoV-2 coronavirus is airborne and that the general public worldwide needs to be aware of this, the WHO (World Health Organization) is still taking a stance that it is not the case but is only spread by large respiratory droplets that, once expelled by infected people in coughs and sneezes, fall quickly to the floor. The WHO lead by black ...

COVID-19 Diagnostics: New Test Kit That Can Differentiate Between COVID-19 And Influenza By US CDC Get FDA Approval. Preparation For Coming Flu Season

Source: COVID-19 Diagnostics Jul 05, 2020 5 years ago

COVID-19 Diagnostics: The US FDA last week on granted Emergency Use Authorization to a new molecular diagnostic test from the US Centers for Disease Control and Prevention that can detect and differentiate the viruses that cause COVID-19 and flu. The new Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time RT-PCR test intended for the simultaneous detection and differ...

COVID-19 Innovations: Kyocera Develops Wearable Remote Monitoring Device For COVID-19 Patients

Source: COVID-19 Innovations Jul 05, 2020 5 years ago

COVID-19 Innovations: The current COVID-19 pandemic has brought a slew of new challenges for clinical facilities, including how to deliver as much care as possible at a distance or remotely not only for precautionary measures to safeguard the wellbeing of healthcare staff but only for better monitoring of COVID-19 patients.. Researchers from the Department of Cardiovascular Medicine at To...

Autoimmunity: Japanese Researchers Identify Proteins Tet2 And Tet3 That Can Prevent Autoimmunity Issues

Source: Autoimmunity Jul 05, 2020 5 years ago

Autoimmunity: In normal roles, the immune system is supposed to protect from external microbial invaders, but sometimes it turns its efforts inward, potentially resulting in autoimmune diseases. Researchers from Osaka University In a new study have discovered how reversible modifications to DNA by certain proteins protect from autoimmune diseases, and conversely, how the absence of these ...

COVID-19 And HIV: Icahn Researchers Say HIV May Not Worsen COVID-19 Outcomes

Source: COVID-19 And HIV Jul 05, 2020 5 years ago

COVID-19 And HIV: Individuals with HIV who were hospitalized with COVID-19 did not have worse results than COVID-19 patients without HIV, according to new research by Icahn School of Medicine at Mount Sinai. The research findings were published in the journal: Clinical Infectious Diseases https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa880/5864410?searchresult=1 Study...

COVID-19 Pharma News: Merck Initiates Clinical Trial Of TLR7 And TLR8 Inhibitor To Treat Severe COVID-19

Source: Jul 05, 2020 5 years ago

COVID-19 Pharma News: Pharma giant Merck, a leading science and technology company, announced that the US FDA has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia. Merck will initiate a Phase II randomized, controlled clinical study evaluating the safety and efficacy of M5049 in this patient population. M5049 is a potentially fi...

Melatonin and COVID-19: More Studies Emerging That Melatonin Is Useful As An Adjuvant Treatment For COVID-19 Due to Its Anti-Inflammatory Properties.

Source: Melatonin and COVID-19 Jul 05, 2020 5 years ago

Melatonin and COVID-19: Another study by researchers from Peking Union Medical College in China and the University of Texas- San Antonio in America have in a new peer-reviewed finding that is published in the journal: Life Sciences By Science Direct, propose that Melatonin should be incorporated as an adjuvant treatment for COVID-19 as it has proven mechanisms to target Inflammasomes that triggers...

COVID-19 Vaccine: China Creates Artificial Protein That Can Be Basis For Broad-Spectrum Vaccine While Others Warn Vaccines Might Not Be Effective Long Term

Source: COVID-19 Vaccine Jul 05, 2020 5 years ago

COVID-19 Vaccine: Researchers from China have created an artificial protein that they say could be the basis of a vaccine to help ward off various deadly coronaviruses, including the pathogen that causes Covid-19 Copyright: Credit: Xinhua The researchers from the Chinese CDC said the approach triggered a strong antibody response in mice and monkey trials to Middle Eas...

Warning! COVID-19 Clinical Care: Alert About Drug Interactions When Treating COVID-19 Patients With Anticancer Drugs While On Antivirals

Source: COVID-19 Clinical Care Jul 04, 2020 5 years ago

COVID-19 Clinical Care: Researchers are expressing that more safety data is needed in terms of treatment of symptomatic COVID-19 patients on antivirals with anticancer drugs. A report published in the European Journal of Cancer by a group of French investigators led by Dr Paul Gougis of the Department of pharmacology, Hôpital Pitié-Salpêtrière in Paris, Franc...

COVID-19 Drugs: U.S. FDA Approves Siltuximab To Treat Acute Respiratory Distress Syndrome (ARDS) In COVID-19 Patients

Source: COVID-19 Drugs Jul 04, 2020 5 years ago

COVID-19 Drugs: EUSA Pharma has secured approval from the U.S. Food & Drug Administration (FDA) for a Phase III clinical trial protocol of intravenous siltuximab plus standard of care in hospitalized patients with Covid-19 associated Acute Respiratory Distress Syndrome (ARDS). The pharmaceutical company will now proceed with the randomized, double-blind, placebo-controlled clinical trial to e...

COVID-19 Vaccine: India’s Second COVID-19 Vaccine By Zydus Cadila Gets Approval For Human Trials

Source: COVID-19 Vaccine Jul 04, 2020 5 years ago

COVID-19 Vaccine: Indian pharmaceutical company, Zydus Cadila received the green signal from the Drug Controller General of India (DGCI) to start phase I and II of their clinical trials on human participants. Over 120 independent scientific bodies are in contention to find a potential COVID-19 vaccine. Over 7 vaccines are being researched in India and just this week, two candidate groups ...

German Researchers Study Brain Oxygen Needs And Correlation With Nerve Cells Activity

Source: Thailand Medical News Jul 04, 2020 5 years ago

The human brain has a high energy demand and reacts very sensitively to oxygen deficiency. Ludwig Maximilian University of Munich neurobiologists have now succeeded for the first time in directly correlating oxygen consumption with the activity of certain nerve cells. Typically, the brain requires a disproportionate amount of energy compared to its body mass. This energy is mainly generat...

HIV Drugs: US FDA Approves Rukobia (Fostemsavir) To Treat Patients With Multidrug Resistant HIV Infection

Source: HIV Drugs Jul 04, 2020 5 years ago

HIV Drugs: The drug Rukobia (fostemsavir) has been approved by The U.S. FDA for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. Rukobia (Fostemsavir) is a new type of antiretroviral medication to be taken twice daily by mouth. It is a prodrug, whi...

COVID-19 Vaccine Updates - Pfizer and BioNTech Publish Positive Interim Phase I/II Data for COVID-19 Vaccine

Source: COVID-19 Vaccine Updates Jul 04, 2020 5 years ago

COVID-19 Vaccine Updates: Pharmaceutical and Biotech giants, Pfizer and BioNTech reported that the most advanced of four constructs of their messenger RNA (mRNA) vaccine candidate for COVID-19 showed encouraging immunogenicity and a favorable safety profile in preliminary Phase I/II data published in a preprint study. https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1 Bot...

COVID-19 Disinfectants: Miramistin A Cold War Antiseptic Has Potential In Fight Against Drug-Resistant Germs And Viruses, Researchers Urge Study For SARS-CoV-2

Source: COVID-19 Disinfectants Jul 04, 2020 5 years ago

COVID-19 Disinfectants: University of Manchester scientists say that a little-known non-toxic antiseptic developed in the Soviet Union during the Cold War has enormous potential to beat common infections and that even detailed studies should be conducted with regards to its use in the current COVID-19 scenario. Their report was published in the journal: FEMS Microbiology Reviews. https://aca...

Could Study That Shows Proteins Nsp12 And 13 Of SARS-Cov-2 Causing Mitochondrial Dysfunction Explain For Prevalence Of Chronic Fatigue Syndrome In COVID-19 Patients?

Source: Chronic Fatigue Syndrome Jul 04, 2020 5 years ago

Chronic Fatigue Syndrome: There has been so many clinical manifestation of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) reported in COVID-19 patients experiencing mild to moderate symptoms and also in typically asymptomatic and also recovered COVID-19 patients. To date medical experts do not have a proper explanation for this. However, browsing through various new COVI...

COVID-19 Research: University Of Bristol Researchers Warn That Liver Complications Are Common In COVID-19 Patients

Source: COVID-19 Research Jul 04, 2020 5 years ago

COVID-19 Research: Researchers from the University Of Bristol in a new review published in the Journal Of Infection indicate that liver complications are common and are associated with more severe disease in patients with COVID-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306105/ or https://www.journalofinfection.com/article/S0163-4453(20)30425-4/pdf Dr Setor K. Kunutsor of Bristol M...

WARNING! COVID-19 Pediatrics: More Children With COVID-19 Discovered To Be Inflicted With Neurological Symptoms

Source: COVID-19 Pediatrics Jul 04, 2020 5 years ago

COVID-19 Pediatrics: Researchers from the University College London Institute of Neurology are warning that children with COVID-19 may present with new neurological symptoms involving the central and peripheral nervous systems, and splenial changes on imaging. The new research findings were published the journal: JAMA Neurology. https://jamanetwork.com/journals/jamaneurology/fullarticle/2...

COVID-19 Drugs: Researchers Advocate Using Erythropoietin (EPO) As An Adjuvant Treatment For COVID-19

Source: COVID-19 Drugs Jul 03, 2020 5 years ago

COVID-19 Drugs and Erythropoietin: German researchers from the Max Planck Institute of Experimental Medicine in Göttingen suggest that the anemia drug Erythropoietin (Epo) which is sometimes misused as doping agent could also be effective against COVID-19. EPO, the growth factor could also mitigate severe disease progression and protect patients from long-term neurological effects when the ...

SARS-COV-2 Mutations: Study Shows That G614 Strain Less Lethal In Short Term Than D614 But Is Aggressive In Transmissions And Multiplies Rapidly

Source: SARS-COV-2 Mutations Jul 03, 2020 5 years ago

SARS-COV-2 Mutations: Virologists and genomic researchers now know that two major variants of the novel coronavirus (SARS-CoV-2) are circulating in the United States and elsewhere at the moment besides the hundreds of minor variants. The variants, called G614 and D614, have just a small difference in their "spike" protein, the viral machinery that coronaviruses use to enter hos...

U.S. COVID-19 News: America Setting New Records Every day. Trump Deserves Badge Of Honor. 53,096 New Infections In Last 24 Hours

Source: U.S. COVID-19 News Jul 03, 2020 5 years ago

U.S. COVID-19 News: America sets a new record in the last 24 hours with 53,069 (Thursday) new coronavirus infections in the last 24 hours. The country now has recorded a total of 2,837,189 COVID-19 Infections of which health authorities claim that 1,191,102 have ‘recovered.’ A total of 131,217 Americans have died from the COVID-19. What is even scarier is that it is reported t...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM MEDICAL STOCK MARKET

LATEST ON GENOMICS AND EPIGENETICS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

Covid 19 vaccine

MOST READ

Interesting Reads

FROM MEDICAL STOCK MARKET

LATEST ON GENOMICS AND EPIGENETICS